Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Immunocore Holdings plc - American Depositary Shares
(NQ:
IMCR
)
29.56
+0.43 (+1.48%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immunocore Holdings plc - American Depositary Shares
< Previous
1
2
3
4
5
6
7
Next >
After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade
↗
November 18, 2022
Bill Gates has two portfolios he makes trades from: the Bill & Melinda Gates Foundation and the Bill & Melinda Gates Foundation Trust.
Via
Benzinga
Immunocore presents new biomarker analysis for KIMMTRAK (tebentafusp-tebn) in metastatic uveal melanoma at the SITC 2022 Annual Meeting
November 11, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
November 11, 2022
Neurocrine Biosciences trended higher with the broad market Thursday, coming within a penny of Tuesday’s high of $125.99. It is forming a bullish channel.
Via
MarketBeat
Where Immunocore Hldgs Stands With Analysts
↗
November 10, 2022
Immunocore Hldgs (NASDAQ:IMCR) has observed the following analyst ratings within the last quarter:
Via
Benzinga
What 6 Analyst Ratings Have To Say About Immunocore Hldgs
↗
October 13, 2022
Analysts have provided the following ratings for Immunocore Hldgs (NASDAQ:IMCR) within the last quarter:
Via
Benzinga
5 Analysts Have This to Say About Immunocore Hldgs
↗
September 14, 2022
Within the last quarter, Immunocore Hldgs (NASDAQ:IMCR) has observed the following analyst ratings:
Via
Benzinga
Immunocore Shares Fall After Early Solid Cancer Trial Data Of TCR Therapy
↗
September 09, 2022
Via
Benzinga
Immunocore to present at the Jefferies London Healthcare Conference
November 10, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore Reports Third Quarter 2022 Financial Results and Provides Business Update
November 09, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
↗
September 09, 2022
Via
Benzinga
Dow Climbs More Than 400 Points, S&P 500 Rises 1.5%
↗
September 09, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 400 points on Friday.
Via
Benzinga
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
↗
September 12, 2022
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in...
Via
Benzinga
Stocks Extend Gains, Weekly Wins In Sight
↗
September 09, 2022
Stocks are extending this morning's gains, with the Dow Jones Industrial Average last seen up 317 points.
Via
Talk Markets
Analyzing Immunocore Hldgs's Short Interest
↗
September 09, 2022
Immunocore Hldgs's (NASDAQ:IMCR) short percent of float has fallen 15.71% since its last report. The company recently reported that it has 902 thousand shares sold short, which is...
Via
Benzinga
Why Zscaler Is Trading Higher By Around 19%, Here Are 44 Stocks Moving In Friday's Mid-Day Session
↗
September 09, 2022
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares jumped 70% to $2.1750 after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in cash.
Via
Benzinga
Nasdaq Jumps Over 200 Points, Crude Oil Rises Sharply
↗
September 09, 2022
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Friday.
Via
Benzinga
Enphase Energy, Immunocore And Some Other Big Stocks Moving Lower On Friday
↗
September 09, 2022
U.S. stocks traded higher, with the Dow Jones gaining around 300 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
US Stocks Open Higher, Dow Surges 300 Points
↗
September 09, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Friday.
Via
Benzinga
Bed Bath & Beyond, Eiger BioPharmaceuticals And Some Other Big Stocks Moving Lower On Tuesday
↗
September 06, 2022
Via
Benzinga
15 Biotech Stocks That Hit Year Highs Over The Last Week, Including Sarepta, Axsome
↗
August 30, 2022
Not all shares are slowing down alongside the industry group.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
↗
September 09, 2022
Upgrades
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
↗
August 08, 2022
Via
Benzinga
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
↗
September 09, 2022
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to...
Via
Benzinga
iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday
↗
August 08, 2022
U.S. stocks closed mixed on Friday following the release of jobs data for July. Here is the list of some big stocks moving higher in the previous session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022
↗
September 08, 2022
Via
Benzinga
Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday
↗
August 05, 2022
U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022
↗
August 02, 2022
Upgrades
Via
Benzinga
The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine
↗
July 18, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Immunocore Commences Initial-Stage HIV Study
↗
July 11, 2022
Immunocore Holdings (NASDAQ: IMCR) has dosed the first patient in the first-in-human Phase 1 clinical trial of IMC-M113V for the treatment of patients with human immunodeficiency virus (HIV)...
Via
Benzinga
4 Biotech Stocks With Bright Prospects To Buy Amid Recovery
↗
June 11, 2022
New drug approvals, acquisitions, and other pipeline developments are back in the spotlight in the biotech industry, following the focus on the development of vaccines and antibody treatments for...
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
